We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWW icon
3751
Outdoor Holding Co
POWW
$288M
$22.9K ﹤0.01%
10,750
-4,870
-31% -$9.52K
DHY
3752
Credit Suisse High Yield Credit Fund
DHY
$242M
$22.7K ﹤0.01%
12,000
GIS icon
3753
PUT
General Mills
GIS
$19.9B
$22K ﹤0.01%
400
CGC
3754
Canopy Growth
CGC
$422M
$20.7K ﹤0.01%
5,327
-784
-13% -$8.23K
TSLA icon
3755
CALL
Tesla
TSLA
$1.32T
$20K ﹤0.01%
100
-500
-83% -$100K
EGLX
3756
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$19.5K ﹤0.01%
38,231
TSP
3757
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$19.1K ﹤0.01%
11,504
-15,366
-57% -$24.9K
IMPL
3758
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$18.4K ﹤0.01%
14,500
MLSS icon
3759
Milestone Scientific
MLSS
$42.8M
$17.4K ﹤0.01%
20,000
HYLN icon
3760
Hyliion Holdings
HYLN
$717M
$16.9K ﹤0.01%
+10,100
New +$17K
PFE icon
3761
CALL
Pfizer
PFE
$153B
$16K ﹤0.01%
400
FTH
3762
Faeth Therapeutics
FTH
$748M
$16K ﹤0.01%
700
PPBT
3763
Purple Biotech
PPBT
$2.51M
$15.3K ﹤0.01%
55
EGIO
3764
DELISTED
Edgio, Inc. Common Stock
EGIO
$14.7K ﹤0.01%
544
+74
+16% +$1.75K
PDYN icon
3765
Palladyne AI
PDYN
$303M
$14.5K ﹤0.01%
7,500
+1,667
+29% +$3.98K
SNCR
3766
DELISTED
Synchronoss Technologies
SNCR
$14.1K ﹤0.01%
1,691
-591
-26% -$4.98K
QTTB icon
3767
Q32 Bio
QTTB
$449M
$14.1K ﹤0.01%
884
AXDX
3768
DELISTED
Accelerate Diagnostics
AXDX
$13.8K ﹤0.01%
1,700
-50
-3% -$375
PAVM icon
3769
PAVmed
PAVM
$32.3M
$13.5K ﹤0.01%
73
VXRT
3770
DELISTED
Vaxart
VXRT
$12.9K ﹤0.01%
17,738
+7,616
+75% +$7.08K
ACHL
3771
DELISTED
Achilles Therapeutics
ACHL
$12.4K ﹤0.01%
+13,096
New +$12.4K
SENS icon
3772
Senseonics Holdings Inc
SENS
$404M
$12.1K ﹤0.01%
792
+70
+10% +$959
MCLD
3773
DELISTED
mCloud Technologies Corp. Common Shares
MCLD
$12K ﹤0.01%
25,677
LMDX
3774
DELISTED
LumiraDx Limited Common Shares
LMDX
$11.5K ﹤0.01%
23,978
-8,863
-27% -$4.61K
FABC
3775
Fabric.AI Inc
FABC
$18.6M
$11.2K ﹤0.01%
127
+49
+63% +$3.61K

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.